Evidence map›Paper›PMID 34436062›Full record

ReviewBiosensors2021

Lab-on-Paper Devices for Diagnosis of Human Diseases Using Urine Samples-A Review.

Wei-Chun Tai, Yu-Chi Chang, Dean Chou, Lung-Ming Fu

Abstract readReview
In one paragraph

Review in Biosensors, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei-Chun TaiDepartment of Oral and Maxillofacial Surgery, Kaohsiung Chang Gung Memorial Hospital, Kaohsiung 833, Taiwan.
Yu-Chi ChangDepartment of Engineering Science, National Cheng Kung University, Tainan 701, Taiwan.
Dean ChouDepartment of Biomedical Engineering, National Cheng Kung University, Tainan 701, Taiwan.
Lung-Ming FuDepartment of Engineering Science, National Cheng Kung University, Tainan 701, Taiwan.ORCID 0000-0002-5422-3811

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In recent years, microfluidic lab-on-paper devices have emerged as a rapid and low-cost alternative to traditional laboratory tests. Additionally, they were widely considered as a promising solution for point-of-care testing (POCT) at home or regions that lack medical infrastructure and resources. This review describes important advances in microfluidic lab-on-paper diagnostics for human health monitoring and disease diagnosis over the past five years. The review commenced by explaining the choice of paper, fabrication methods, and detection techniques to realize microfluidic lab-on-paper devices. Then, the sample pretreatment procedure used to improve the detection performance of lab-on-paper devices was introduced. Furthermore, an in-depth review of lab-on-paper devices for disease measurement based on an analysis of urine samples was presented. The review concludes with the potential challenges that the future development of commercial microfluidic lab-on-paper platforms for human disease detection would face.

Indexed as

Lab-On-A-Chip DevicesMicrofluidic Analytical TechniquesHumansMicrofluidicsPaperPoint-of-Care Testinglab-on-papermicrofluidicnon-invasive samplespaper-based devicesurine

Identifiers

PMID34436062
PMCPMC8393526

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.